RESUMO

Recently, fish byproducts have been appraised as a source of structurally diverse bioactive compounds. In this context, fish mucus has revealed a myriad of pharmacological activities. This study describes a new bioactive molecule release system composed of protein nanoparticles from pacamã (Lophiosilurus alexandri) mucus, an endemic fish to the São Francisco River (Brazil). The process of obtaining and applying these nanoparticles, composed of proteins present in the pacamã mucus, as biocompatible carriers of bioactive molecules is also addressed herein. Therefore, the external mucus of the fish was collected, lyophilized and hydrated in deionized water containing the template molecule. After pH adjustment to 7.5, followed by sonication and centrifugation, the formed nanoparticles were collected in the supernatant. Additionally, the mucus and the particles were characterized, and pharmacological effects were evaluated regarding their antifungal, antibacterial, anticancer, anti or pro-inflammatory and antinociceptive proprieties. NP-Mucus did not exhibit antibacterial activity against Pseudomonas aeruginosa or Staphylococcus aureus. However, it showed potential effects against Candida albicans with a minimum inhibitory concentration (MIC) of 1 µg/mL, and significant pro-inflammatory role, reflected by cellular recruitment activity and healing effects. Therefore, future studies are now needed in order to identify specific compounds in NP-mucus responsible for the observed effects in order to provide new pharmacological and therapeutic strategies.

Recentemente, os subprodutos de peixes foram avaliados como uma fonte de compostos bioativos estruturalmente diversos. Nesse contexto, o muco dos peixes revelou uma miríade de atividades farmacológicas. Este estudo descreve um novo sistema de liberação de moléculas bioativas compostas por nanopartículas de proteínas do muco do pacamã (Lophiosilurus alexandri), um peixe do Rio São Francisco (Brasil). O processo de obtenção e aplicação dessas nanopartículas, compostas por proteínas presentes no muco do pacamã, como carreadores biocompatíveis de moléculas bioativas também são abordados neste artigo. Para tanto, o muco externo dos peixes foi coletado, liofilizado e hidratado em água deionizada contendo a molécula template. Após ajuste do pH para 7,5, seguido de sonicação e centrifugação, as nanopartículas formadas foram coletadas no sobrenadante. Adicionalmente, foram caracterizados o muco e as partículas, sendo avaliados os efeitos farmacológicos quanto às propriedades antifúngicas, antibacterianas, anticancerígenas, anti ou pró-inflamatórias e antinociceptivas. NP-Mucus não exibiu atividade antibacteriana contra Pseudomonas aeruginosa ou Staphylococcus aureus. No entanto, apresentou efeitos potenciais contra Candida albicans com concentração inibitória mínima (MIC) de 1 µg/mL, além de importante papel próinflamatório, refletido pela atividade de recrutamento celular e efeitos cicatrizantes. Portanto, estudos são necessários para identificar compostos no NP-muco responsáveis pelos efeitos observados, a fim de fornecer novas estratégias farmacológicas e terapêuticas.

Assuntos

RESUMO

Recently, fish byproducts have been appraised as a source of structurally diverse bioactive compounds. In this context, fish mucus has revealed a myriad of pharmacological activities. This study describes a new bioactive molecule release system composed of protein nanoparticles from pacamã (Lophiosilurus alexandri) mucus, an endemic fish to the São Francisco River (Brazil). The process of obtaining and applying these nanoparticles, composed of proteins present in the pacamã mucus, as biocompatible carriers of bioactive molecules is also addressed herein. Therefore, the external mucus of the fish was collected, lyophilized and hydrated in deionized water containing the template molecule. After pH adjustment to 7.5, followed by sonication and centrifugation, the formed nanoparticles were collected in the supernatant. Additionally, the mucus and the particles were characterized, and pharmacological effects were evaluated regarding their antifungal, antibacterial, anticancer, anti or pro-inflammatory and antinociceptive proprieties. NP-Mucus did not exhibit antibacterial activity against Pseudomonas aeruginosa or Staphylococcus aureus. However, it showed potential effects against Candida albicans with a minimum inhibitory concentration (MIC) of 1 µg/mL, and significant pro-inflammatory role, reflected by cellular recruitment activity and healing effects. Therefore, future studies a

RESUMO

Recently, fish byproducts have been appraised as a source of structurally diverse bioactive compounds. In this context, fish mucus has revealed a myriad of pharmacological activities. This study describes a new bioactive molecule release system composed of protein nanoparticles from pacamã (Lophiosilurus alexandri) mucus, an endemic fish to the São Francisco River (Brazil). The process of obtaining and applying these nanoparticles, composed of proteins present in the pacamã mucus, as biocompatible carriers of bioactive molecules is also addressed herein. Therefore, the external mucus of the fish was collected, lyophilized and hydrated in deionized water containing the template molecule. After pH adjustment to 7.5, followed by sonication and centrifugation, the formed nanoparticles were collected in the supernatant. Additionally, the mucus and the particles were characterized, and pharmacological effects were evaluated regarding their antifungal, antibacterial, anticancer, anti or pro-inflammatory and antinociceptive proprieties. NP-Mucus did not exhibit antibacterial activity against Pseudomonas aeruginosa or Staphylococcus aureus. However, it showed potential effects against Candida albicans with a minimum inhibitory concentration (MIC) of 1 µg/mL, and significant pro-inflammatory role, reflected by cellular recruitment activity and healing effects. Therefore, future studies are now needed in order to identify specific compounds in NP-mucus responsible for the observed effects in order to provide new pharmacological and therapeutic strategies.(AU)

Recentemente, os subprodutos de peixes foram avaliados como uma fonte de compostos bioativos estruturalmente diversos. Nesse contexto, o muco dos peixes revelou uma miríade de atividades farmacológicas. Este estudo descreve um novo sistema de liberação de moléculas bioativas compostas por nanopartículas de proteínas do muco do pacamã (Lophiosilurus alexandri), um peixe do Rio São Francisco (Brasil). O processo de obtenção e aplicação dessas nanopartículas, compostas por proteínas presentes no muco do pacamã, como carreadores biocompatíveis de moléculas bioativas também são abordados neste artigo. Para tanto, o muco externo dos peixes foi coletado, liofilizado e hidratado em água deionizada contendo a molécula template. Após ajuste do pH para 7,5, seguido de sonicação e centrifugação, as nanopartículas formadas foram coletadas no sobrenadante. Adicionalmente, foram caracterizados o muco e as partículas, sendo avaliados os efeitos farmacológicos quanto às propriedades antifúngicas, antibacterianas, anticancerígenas, anti ou pró-inflamatórias e antinociceptivas. NP-Mucus não exibiu atividade antibacteriana contra Pseudomonas aeruginosa ou Staphylococcus aureus. No entanto, apresentou efeitos potenciais contra Candida albicans com concentração inibitória mínima (MIC) de 1 µg/mL, além de importante papel próinflamatório, refletido pela atividade de recrutamento celular e efeitos cicatrizantes. Portanto, estudos são necessários para identificar compostos no NP-muco responsáveis pelos efeitos observados, a fim de fornecer novas estratégias farmacológicas e terapêuticas.(AU)

Assuntos

RESUMO

Establishing new animal models for the study of inflammation is very important in the process of discovering new drugs, since the inflammatory event is the basis of many pathological processes. Whereas rodent models have been the primary focus of inflammation research, we defend the zebrafish (Danio rerio) test as a feasible alternative for preclinical studies. Moreover, despite all the technological development already achieved by humanity, nature can still be considered a relevant source of new medicines. In this context, the aim of this work was to evaluate the anti-inflammatory effect of a substance isolated from the medicinal plant Annona crassilfora Mart, the peltatoside, in an inflammatory model of zebrafish. It was determined: (i) total leukocyte count in the coelomate exudate; (ii) N-acetyl-ß-d-glucuronidase (NAG); (iii) myeloperoxidase (MPO); (iv) and the histology of liver, intestine and mesentery. Peltotoside (25, 50 and 100 µg) and dexamethasone (25 µg) were administered intracelomatically (i.c.) 30 min before carrageenan (i.c.). Pretreatment with peltatoside at three doses significantly inhibited leukocyte recruitment in the coelomic cavity, and inhibited NAG and MPO activity against the action of Cg, in a similar manner as dexamethasone. However, some microlesions in the evaluated organs were detected. The dose of 25 µg showed an anti-inflammatory effect with lower undesirable effects in the tissues. Our results suggest that the zebrafish test was satisfactory in performing our analyzes and that the peltotoside has a modulatory action in reducing leukocyte migration.

Assuntos

RESUMO

Melanomacrophage centres (MMCs) are formed by macrophage aggregates containing pigments such as hemosiderin, melanin and lipofuscin. MMCs are found in animals such as reptiles, amphibians and, mainly, fishes, in organs such as the kidney, spleen, thymus and liver. In teleost fish, several functions have been attributed to MMCs, including the capture and storage of cations, the phagocytosis of cellular debris and immunological reactions. As the use of MMCs has been suggested as a tool for the assessment of environmental impacts, our aim has been to describe the various metabolic processes performed by MMCs in diverse organs (liver and spleen) by using the teleost Prochilodus argenteus as an animal model. MMCs from the liver and spleen were assessed by histochemistry, transmission electron microscopy, scanning electron microscopy, X-ray microanalysis techniques and biochemical assay for N-acetylglucosaminidase activity. The data showed metabolic differences in MMCs between the liver and spleen of P. argenteus in their morphometric characteristics and biochemical and elemental composition. The implications of these findings are discussed, focusing on their role in organ metabolism.

Assuntos